Cargando…

Chemerin Is Induced in Non-Alcoholic Fatty Liver Disease and Hepatitis B-Related Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is a frequent liver cancer and high expression of bioactive chemerin in hepatocytes was protective in experimental HCC models. The main risk factors for HCC are non-alcoholic fatty liver disease (NAFLD), hepatitis B and C infections. The current analysi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haberl, Elisabeth M., Feder, Susanne, Pohl, Rebekka, Rein-Fischboeck, Lisa, Dürholz, Kerstin, Eichelberger, Laura, Wanninger, Josef, Weiss, Thomas S., Buechler, Christa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602083/ https://www.ncbi.nlm.nih.gov/pubmed/33066325 http://dx.doi.org/10.3390/cancers12102967

Ejemplares similares

Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis
por: Pohl, Rebekka, et al.
Publicado: (2022)

Chemerin Overexpression in the Liver Protects against Inflammation in Experimental Non-Alcoholic Steatohepatitis
por: Pohl, Rebekka, et al.
Publicado: (2022)

Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma
por: Haberl, Elisabeth M., et al.
Publicado: (2019)

Variations in hepatic lipid species of age-matched male mice fed a methionine-choline-deficient diet and housed in different animal facilities
por: Rein-Fischboeck, Lisa, et al.
Publicado: (2019)

Hepatic lipid profile in mice fed a choline-deficient, low-methionine diet resembles human non-alcoholic fatty liver disease
por: Haberl, Elisabeth M., et al.
Publicado: (2020)

Chemerin Isoforms and Activity in Obesity
por: Buechler, Christa, et al.
Publicado: (2019)

Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice
por: Haberl, Elisabeth M., et al.
Publicado: (2021)

Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma
por: Feder, Susanne, et al.
Publicado: (2019)

Adipokines in Liver Cirrhosis
por: Buechler, Christa, et al.
Publicado: (2017)

Chemokine-Like Receptor 1 mRNA Weakly Correlates with Non-Alcoholic Steatohepatitis Score in Male but Not Female Individuals
por: Neumann, Maximilian, et al.
Publicado: (2016)

Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients
por: Feder, Susanne, et al.
Publicado: (2020)

Chemerin Isoform-Specific Effects on Hepatocyte Migration and Immune Cell Inflammation
por: Feder, Susanne, et al.
Publicado: (2020)

Chemerin and Cancer
por: Treeck, Oliver, et al.
Publicado: (2019)

Chemerin Signaling in Cancer
por: Treeck, Oliver, et al.
Publicado: (2020)

Chemerin and Chemokine-like Receptor 1 Expression Are Associated with Hepatocellular Carcinoma Progression in European Patients
por: Weber, Florian, et al.
Publicado: (2023)

Chemerin-156 is the Active Isoform in Human Hepatic Stellate Cells
por: Spirk, Marlen, et al.
Publicado: (2020)

Adiponectin Isoforms Differentially Affect Gene Expression and the Lipidome of Primary Human Hepatocytes
por: Wanninger, Josef, et al.
Publicado: (2014)

Chemerin and Chemokine-like Receptor 1 Expression in Ovarian Cancer Associates with Proteins Involved in Estrogen Signaling
por: Weber, Florian, et al.
Publicado: (2023)

Plasma Chemerin Is Induced in Critically Ill Patients with Gram-Positive Infections
por: Amend, Pablo, et al.
Publicado: (2023)

Anti-Tumoral Effect of Chemerin on Ovarian Cancer Cell Lines Mediated by Activation of Interferon Alpha Response
por: Schmitt, Meike, et al.
Publicado: (2022)

Chemerin Is a Valuable Biomarker in Patients with HCV Infection and Correlates with Liver Injury
por: Peschel, Georg, et al.
Publicado: (2020)

Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma
por: Haberl, Elisabeth M., et al.
Publicado: (2021)

Urinary chemerin as a potential biomarker for inflammatory bowel disease
por: Gunawan, Stefan, et al.
Publicado: (2022)

Loss of Chemerin in Rhabdomyosarcoma Cells Polarizes Adjacent Monocytes to an Immunosuppressive Phenotype
por: Sun, Rui, et al.
Publicado: (2022)

Pro-Resolving Molecules—New Approaches to Treat Sepsis?
por: Buechler, Christa, et al.
Publicado: (2017)

Proprotein convertase subtilisin/kexin type 9 (PCSK9) levels are not associated with severity of liver disease and are inversely related to cholesterol in a cohort of thirty eight patients with liver cirrhosis
por: Feder, Susanne, et al.
Publicado: (2021)

Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Hatziagelaki, Erifili, et al.
Publicado: (2015)

Higher serum levels of short-chain fatty acids are associated with non-progression to arthritis in individuals at increased risk of RA
por: Martinsson, Klara, et al.
Publicado: (2022)

Regulatory effect of chemerin and therapeutic efficacy of chemerin-9 in pancreatogenic diabetes mellitus
por: Tu, Jianfeng, et al.
Publicado: (2020)

Associations of circulating chemerin and adiponectin concentrations with hepatic steatosis
por: Levin, Lena-Maria, et al.
Publicado: (2019)

Ligand-binding and -scavenging of the chemerin receptor GPR1
por: Fischer, Tobias F., et al.
Publicado: (2021)

International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin(1)) and GPR1 (Chemerin(2)) Nomenclature, Pharmacology, and Function
por: Kennedy, Amanda J., et al.
Publicado: (2018)

The Expression and Regulation of Chemerin in the Epidermis
por: Banas, Magdalena, et al.
Publicado: (2015)

Chemerin promotes angiogenesis in vivo
por: Nakamura, Nobuhisa, et al.
Publicado: (2018)

Chemerin Forms: Their Generation and Activity
por: Zhao, Lei, et al.
Publicado: (2022)

Role of Chemerin in Cardiovascular Diseases
por: Macvanin, Mirjana T., et al.
Publicado: (2022)

The Chemerin Receptor CMKLR1 Requires Full‐Length Chemerin for High Affinity in Contrast to GPR1 as Demonstrated by a New Nanoluciferase‐Based Binding Assay
por: Czerniak, Anne Sophie, et al.
Publicado: (2022)

Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis
por: Li, Jing-Jing, et al.
Publicado: (2018)

Impact of Serum Chemerin Levels on Liver Functional Reserves and Platelet Counts in Patients with Hepatocellular Carcinoma
por: Imai, Kenji, et al.
Publicado: (2014)

Chemerin reveals its chimeric nature
por: Yoshimura, Teizo, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_8i7bmpj9mbhfcmj8tn0u3sfj7l